These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Modern gastritis therapy. New pathogenetic concepts. Significance of Campylobacter pylori. Use of bismuth compounds. Report of the 16th meeting of the Bayern Society of Gastroenterology. Bad Dürkheim, 21-22 October 1988]. Fortschr Med Suppl; 1989; 55():1-15. PubMed ID: 2917722 [No Abstract] [Full Text] [Related]
9. [Drug therapy of Campylobacter pylori-associated gastritis]. Bielefeldt K Dtsch Med Wochenschr; 1988 Sep; 113(38):1495-6. PubMed ID: 3168772 [No Abstract] [Full Text] [Related]
10. The treatment of Campylobacter-associated gastritis. McNulty CA Am J Gastroenterol; 1987 Mar; 82(3):245-7. PubMed ID: 3493685 [No Abstract] [Full Text] [Related]
11. [Is gastric acid secretion inhibition necessary for successful eradication of Helicobacter pylori?]. Müller P; Simon B Fortschr Med; 1996 Aug; 114(22-23):275-6. PubMed ID: 8974962 [No Abstract] [Full Text] [Related]
12. Rhodococcus equi infections: antibiotic therapy and relapses. Giacometti A; Cirioni O; Burzacchini F; Del Prete MS; Balducci M; al Natour I; Scalise G AIDS; 1997 Jan; 11(1):120-1. PubMed ID: 9110086 [No Abstract] [Full Text] [Related]
13. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases]. Caspary WF; Arnold R; Bayerdörffer E; Behrens R; Birkner B; Braden B; Domschke W; Labenz J; Koletzko S; Malfertheiner P; Menge H; Rösch W; Schepp W; Strauch M; Stolte M Z Gastroenterol; 1996 Jun; 34(6):392-401. PubMed ID: 8767830 [No Abstract] [Full Text] [Related]
15. Whipple's disease with muscle impairment. Puget M; Iwaz J; Tristan A; Streichenberger N Muscle Nerve; 2006 Dec; 34(6):794-8. PubMed ID: 16967496 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of Helicobacter pylori infection: current status]. Wagner S; Gebel M; Manns M Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of Helicobacter pylori infection in adults]. Boixeda D Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370 [No Abstract] [Full Text] [Related]
18. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori]. Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414 [No Abstract] [Full Text] [Related]
19. Rhodococcus equi infections: clinical features and laboratory diagnosis. Cornish N; Washington JA Curr Clin Top Infect Dis; 1999; 19():198-215. PubMed ID: 10472487 [No Abstract] [Full Text] [Related]
20. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis. Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]